Reliance Research and Development Services Private Limited
About Reliance Research and Development Services Private Limited
Data last updated:
Reliance Research and Development Services Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 27 December 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U15300MH1999PTC123316.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Parte Manohar and Vijay Ramniwas Agarwal.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 85 – A Mittal Court 8th Floor 224 Nariman Ppoint, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹33,502. For the same year it recorded a net profit of ₹16,945 (net margin 50.6%) and EBITDA of ₹22,585 (EBITDA margin 67.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 23% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Reliance Research and Development Services Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address85 – A Mittal Court 8th Floor 224 Nariman Ppoint, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Reliance Research and Development Services Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reliance Research and Development Services Private Limited
FY 2025 filings availableReliance Research and Development Services Private Limited reported revenue of ₹33,502 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,585 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16,945 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 67.4% | ||||
| Net Profit Margin | 50.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reliance Research and Development Services Private Limited, buy the company report.
Board of directors of Reliance Research and Development Services Private Limited
Reliance Research and Development Services has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Parte Manohar Also directs: Rivansh Properties LLP, Reliance Agrotech Private Limited, Ashita Texturising Private Limited and 5 more | Director | 11 Jun 2018 | 8 Years 4 Months | Current |
| Vijay Ramniwas Agarwal Also directs: Amritkalash Commercial LLP, Reliance Logistics and Ports LLP, Reliance Group Tradecom LLP and 5 more | Director | 11 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Reliance Research and Development Services Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novita Healthntech Private Limited | ₹40,389 (FY 2023) | 8.0% | Hyderabad, Telangana, India | |||
| Institute of Pharmaceutical & Healthcare Management and Rese | ₹39,624 (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| SHL Research Private Limited | ₹38,000 (FY 2025) | 12.0% | Chennai, Tamil Nadu, India | |||
| Encure Medical Private Limited | ₹35,452 (FY 2025) | 22.0% | Thane, Maharashtra, India | |||
| Cyto-Sure Private Limited | ₹35,400 (FY 2022) | Bangalore, Karnataka, India | ||||
| Reliance Research and Development Services Private Limitedthis company | ₹33,502 (FY 2025) | ₹16,945 | 50.6% | Mumbai, Maharashtra, India | ||
| Dhathri Ayurveda Hospitals and Researches Private Limited | ₹33,300 (FY 2025) | Ernakulam, Kerala, India | ||||
| Avyatha Medical Research Projects Private Limited | ₹32,133 (FY 2025) | -96.0% | Dhampur, Uttar Pradesh, India | |||
| International Medical Research & Scientific Center Private Limited | ₹25,000 (FY 2024) | -92.0% | Kanpur, Uttar Pradesh, India | |||
| Clinovation Research Private Limited | ₹23,530 (FY 2023) | 0.0% | Kolkata, West Bengal, India | |||
| Nexus Clinical Research (India) Limited | ₹23,490 (FY 2025) | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Reliance Research and Development Services Private Limited, buy the company report.
Auditor
Reliance Research and Development Services Private Limited is audited by V.P.MEHTA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.P.MEHTA & CO. | FY 2023 | 106326W |
Shareholding
The shareholding of Reliance Research and Development Services Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Reliance Research and Development Services Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reliance Research and Development Services Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reliance Research and Development Services Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reliance Research and Development Services Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reliance Research and Development Services Private Limited has 10 board changes on record since 2010: 2 appointments and 8 cessations. The latest: Rajesh Parte Manohar ceased to be Additional Director on 10 Sep 2018.
1 earlier event is in the company report.
Frequently asked questions
Reliance Research and Development Services is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 27 December 1999 (27+ years old) and is registered under CIN U15300MH1999PTC123316.
Reliance Research and Development Services has 2 current directors:
- Rajesh Parte Manohar - Director
- Vijay Ramniwas Agarwal - Director
The latest financial statements of Reliance Research and Development Services on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Reliance Research and Development Services is U15300MH1999PTC123316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reliance Research and Development Services was incorporated on 27 December 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Reliance Research and Development Services by revenue are Novita Healthntech Private Limited, Institute of Pharmaceutical & Healthcare Management and Rese, SHL Research Private Limited, Encure Medical Private Limited, Cyto-Sure Private Limited and 5 more, all in the Pharma industry (Contract Research).
Rajesh Parte Manohar ceased to be Additional Director on 10 Sep 2018. Vijay Ramniwas Agarwal ceased to be Additional Director on 10 Sep 2018. Girish Balubhai Shah ceased to be Director on 11 Jun 2018. Reliance Research and Development Services has 10 board changes on record in total.
The registered office of Reliance Research and Development Services is at 85 – A Mittal Court 8th Floor 224 Nariman Ppoint, Mumbai, Maharashtra, India – 400021.
Reliance Research and Development Services operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Reliance Research and Development Services is compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.
Reliance Research and Development Services can be reached at its registered office: 85 – A Mittal Court 8th Floor 224 Nariman Ppoint, Mumbai, Maharashtra, India – 400021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
